Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antioxidant Approach as a Cardioprotective Strategy in Chemotherapy-Induced Cardiotoxicity
Christian Cadeddu Dessalvi, Martino Deidda, Antonio Noto, et al.
Antioxidants and Redox Signaling (2020) Vol. 34, Iss. 7, pp. 572-588
Closed Access | Times Cited: 20

Showing 20 citing articles:

Endothelial dysfunction as a complication of anti-cancer therapy
Janée D. Terwoord, Andreas Beyer, David D. Gutterman
Pharmacology & Therapeutics (2022) Vol. 237, pp. 108116-108116
Open Access | Times Cited: 46
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for osimertinib
Yanchao Yin, Yamin Shu, Junru Zhu, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 41
Knockdown ATG5 gene by rAAV9 alleviates doxorubicin-induced cardiac toxicity by inhibiting GATA4 autophagic degradation
Ai-Li Xu, Zheng Shen, Shihao Wang, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access | Times Cited: 1
Cardioprotective potential of vanillic acid
Banafsheh Yalameha, Hamid Reza Nejabati, Mohammad Nouri
Clinical and Experimental Pharmacology and Physiology (2022) Vol. 50, Iss. 3, pp. 193-204
Closed Access | Times Cited: 32
Palmatine attenuates the doxorubicin-induced inflammatory response, oxidative damage and cardiomyocyte apoptosis
Dongliang Cheng, Ping Liu, Zhiwei Wang
International Immunopharmacology (2022) Vol. 106, pp. 108583-108583
Closed Access | Times Cited: 22
A real-world pharmacovigilance study of polatuzumab vedotin based on the FDA adverse event reporting system (FAERS)
Dan Liu, Wei Mao, Bin Hu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Multifaceted Cardioprotective Potential of Reduced Glutathione Against Doxorubicin-Induced Cardiotoxicity via Modulating Inflammation–Oxidative Stress Axis
Amr Negm, Ezat A. Mersal, Amal F. Dawood, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3201-3201
Open Access
Approaches for reducing chemo/radiation-induced cardiotoxicity by nanoparticles
Ketao Li, Wan Chen, Liping Ma, et al.
Environmental Research (2023) Vol. 244, pp. 117264-117264
Closed Access | Times Cited: 7
Role of parthenolide in paclitaxel-induced oxidative stress injury and impaired reproductive function in rat testicular tissue
Emine Toraman, Büşra Budak, Cemil Bayram, et al.
Chemico-Biological Interactions (2023) Vol. 387, pp. 110793-110793
Closed Access | Times Cited: 7
A review of cardioprotective effect of ginsenosides in chemotherapy-induced cardiotoxicity
Hadi Zare‐Zardini, Mohammad-Taghi Hedayati-Goudarzi, A Fazl Alizadeh, et al.
BioMedical Engineering OnLine (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Cardiotoxicity linked to anticancer agents and cardioprotective strategy
Shraddha I. Khairnar, Yogesh A. Kulkarni, Kavita Singh
Archives of Pharmacal Research (2022) Vol. 45, Iss. 10, pp. 704-730
Closed Access | Times Cited: 10
Long-term cardiovascular mortality risk in patients with bladder cancer: a real-world retrospective study of 129,765 cases based on the SEER database
Jia Liao, Zihua Zhou
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 5
Gallic acid inhibits celecoxib-induced mitochondrial permeability transition and reduces its toxicity in isolated cardiomyocytes and mitochondria
Ahmad Salimi, Saman Atashbar, Mohammad Shabani
Human & Experimental Toxicology (2021) Vol. 40, Iss. 12_suppl, pp. S530-S539
Open Access | Times Cited: 9
Benefits of β-blockers in cancer treatment
Mohamad Arif, Mardiah Suci Hardianti, Nurina Tyagita, et al.
Oncology in Clinical Practice (2022) Vol. 19, Iss. 2, pp. 90-100
Open Access | Times Cited: 6
Systematical Evaluation of the Structure-Cardiotoxicity Relationship of 7-Azaindazole-based PI3K Inhibitors Designed by Bioisosteric Approach
Tianze Wu, Yi Chen, Chengbin Yang, et al.
Cardiovascular Toxicology (2023) Vol. 23, Iss. 11-12, pp. 364-376
Closed Access | Times Cited: 3
In Vivo Murine Models of Cardiotoxicity Due to Anticancer Drugs: Challenges and Opportunities for Clinical Translation
Serena L’Abbate, Michela Chianca, Iacopo Fabiani, et al.
Journal of Cardiovascular Translational Research (2022) Vol. 15, Iss. 5, pp. 1143-1162
Closed Access | Times Cited: 4
Health effects of outdoor water sports in chronic disease: a scoping review
Lucia Cugusi, Martina Meloni, Marco Bergamin, et al.
Sport Sciences for Health (2022) Vol. 19, Iss. 1, pp. 1-15
Open Access | Times Cited: 3
A Comprehensive View on Drugs-Induced Cardiotoxicity and Its Prevention
Abdulnaser Ali, Musab Khalaf, Abdulla Ahmad
˜Al-œMağallaẗ al-ʻirāqiyyaẗ li-l-ṣaydalaẗ (2024) Vol. 21, Iss. 1, pp. 20-35
Open Access
Methanolic Extract of Morchella esculenta (Ascomycota), Prevents Chemotherapy Related Cardiotoxicity in Tumour Bearing Mice
Sneha Das, Anjana Mathew, K. K. Janardhanan
International journal of medicinal mushrooms (2024) Vol. 27, Iss. 1, pp. 51-61
Closed Access
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for Osimertinib
Yanchao Yin, Yamin Shu, Junru Zhu, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Page 1

Scroll to top